204 related articles for article (PubMed ID: 20526555)
21. A rare case of isoniazid-induced erythroderma.
Garg Y; Gore R; Jain S; Kumar A
Indian J Pharmacol; 2015; 47(6):682-4. PubMed ID: 26729965
[TBL] [Abstract][Full Text] [Related]
22. Psoriasiform type of lichen scrofulosorum: clue to disseminated tuberculosis.
Kumar U; Sethuraman G; Verma P; Das P; Sharma VK
Pediatr Dermatol; 2011; 28(5):532-4. PubMed ID: 21133997
[TBL] [Abstract][Full Text] [Related]
23. [Skin manifestations caused by the medicamentous allergy to the first antituberculous drugs].
Horvat M; Jakasa D; Radielović P
Tuberkuloza; 1966; 18(1-3):90-4. PubMed ID: 16296073
[No Abstract] [Full Text] [Related]
24. An asthmatic case of psoriasiform eruption caused by administration of dupilumab.
Matsuda T; Yamada H; Hida N; Nakaizumi T; Yamada E; Satoh H; Hizawa N
Allergol Int; 2020 Jul; 69(3):478-479. PubMed ID: 32178985
[No Abstract] [Full Text] [Related]
25. Isoniazid-induced bullous skin reaction.
Scheid P; Kanny G; Tréchot P; Rosner V; Ménard O; Vignaud JM; Anthoine D; Martinet Y
Allergy; 1999 Mar; 54(3):294-6. PubMed ID: 10321574
[No Abstract] [Full Text] [Related]
26. Lichenoid drug eruption induced by colchicine: case report.
An I; Demir V; Akdeniz S
Cutan Ocul Toxicol; 2017 Jun; 36(2):199-200. PubMed ID: 27345420
[TBL] [Abstract][Full Text] [Related]
27. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
28. Psoriasiform Eruption Secondary to the Use of Adalimumab.
Esteves PM; Barbalho MG; Cortes JG; Cuzzi T; Sodre CT; Ramos-e-Silva M
J Drugs Dermatol; 2015 Oct; 14(10):1152-4. PubMed ID: 26461828
[TBL] [Abstract][Full Text] [Related]
29. Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Lacouture ME; Goleva E; Shah N; Rotemberg V; Kraehenbuehl L; Ketosugbo KF; Merghoub T; Maier T; Bang A; Gu S; Salvador T; Moy AP; Lyubchenko T; Xiao O; Hall CF; Berdyshev E; Crooks J; Weight R; Kern JA; Leung DYM
Clin Cancer Res; 2024 Jul; 30(13):2822-2834. PubMed ID: 38652814
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect.
Garcovich S; Burlando M; Rongioletti F; Garcovich A; Parodi A; Amerio P
Acta Derm Venereol; 2010 May; 90(3):311-2. PubMed ID: 20526559
[No Abstract] [Full Text] [Related]
31. Tocilizumab-induced pustular drug eruption.
Mori T; Yamamoto T
Int J Rheum Dis; 2017 Nov; 20(11):1776-1777. PubMed ID: 26218136
[No Abstract] [Full Text] [Related]
32. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.
Antonucci A; Bardazzi F; Balestri R; Patrizi A
J Dermatolog Treat; 2009; 20(1):61-2. PubMed ID: 18618361
[TBL] [Abstract][Full Text] [Related]
33. Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
Darrigade AS; Milpied B; Truchetet ME; Schaeverbeke T; Laharie D; Zerbib F; Beylot-Barry M; Jouary T; Taïeb A; Ezzedine K; Seneschal J
Acta Derm Venereol; 2017 Jun; 97(6):731-734. PubMed ID: 28218339
[TBL] [Abstract][Full Text] [Related]
34. Development of a prominent granulomatous eruption after interferon-gamma therapy in a patient with mycosis fungoides.
Haruyama S; Sugita K; Kawakami C; Nakamura M; Tokura Y
Acta Derm Venereol; 2010 Mar; 90(2):190-1. PubMed ID: 20169308
[No Abstract] [Full Text] [Related]
35. Psoriasiform eruption induced by propranolol.
Halevy S; Feuerman EJ
Cutis; 1979 Jul; 24(1):95-8. PubMed ID: 157852
[TBL] [Abstract][Full Text] [Related]
36. [Multiple allergy to antitubercular agents as a cause of unsuccessful treatment of pulmonary tuberculosis].
Popović J; Praso R
Plucne Bolesti Tuberk; 1974; 26 Suppl 2():101-4. PubMed ID: 4280599
[No Abstract] [Full Text] [Related]
37. Prevalence of cutaneous drug eruptions in adult Nigerians with HIV/AIDS.
Salami TA; Asalu AF; Samuel SO
Niger Postgrad Med J; 2010 Jun; 17(2):160-3. PubMed ID: 20539333
[TBL] [Abstract][Full Text] [Related]
38. Erythema multiforme-like irritant contact dermatitis after application of an antiscabies treatment.
Bassi A; D'Erme AM; Gola M
Int J Immunopathol Pharmacol; 2011; 24(2):545-7. PubMed ID: 21658333
[TBL] [Abstract][Full Text] [Related]
39. [Cutaneous lesions due to lithium therapy (author's transl)].
Lambert D; Beer F; Gisselman R; Bouilly D; Chapuis JL
Ann Dermatol Venereol; 1982; 109(1):19-24. PubMed ID: 6462094
[TBL] [Abstract][Full Text] [Related]
40. [Clinico-immunological characteristics of drug allergy in patients with pulmonary tuberculosis].
Pukhlik BM; Mzaiĕk V; Zaikov SV
Probl Tuberk; 1991; (6):46-7. PubMed ID: 1838178
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
